Acute Myeloid Leukemia Clinical Trials in Nuremberg
3 recruitingNuremberg, Germany
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMixed Phenotype Acute Leukemia+2 more
Syndax Pharmaceuticals447 enrolled57 locationsNCT04065399
Recruiting
Phase 1Phase 2
Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)
Acute Myeloid Leukemia
Technische Universität Dresden214 enrolled21 locationsNCT04385290
Recruiting
Phase 2
Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML
Acute Myeloid Leukemia
Technische Universität Dresden146 enrolled18 locationsNCT05904106